Doctor profile · Federal record
Dr. Michelle Bussmann, MD
Dermatology Physician (CMS: Dermatology) · Edina, MN
- NPI 1811097579
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 33 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3316 W 66Th St, Ste 200
Edina, MN 554352506
(952) 920-3808
fax (952) 920-8899
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Minnesota #37787
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1811097579. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,206
Distinct HCPCS
10
Medicare allowed
$220,660
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,030 | 202 | $7 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 617 | 479 | $125 | |
17000 |
Destruction of precancer skin growth, 1 growth | 450 | 310 | $50 | |
11102 |
Biopsy of related skin growth, first growth | 188 | 161 | $88 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 171 | 148 | $88 | |
17110 |
Destruction of skin growth, 1-14 growths | 147 | 118 | $105 | |
11301 |
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 104 | 88 | $109 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 59 | 16 | $1 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 57 | 46 | $149 | |
11103 |
Biopsy of related skin growth, each additional growth | 56 | 43 | $50 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 159. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$278
Transactions
16
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Incyte Corporation | 2 | $42.00 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $27.42 | |
| ABBVIE INC. | 1 | $25.05 | |
| UCB, Inc. | 1 | $22.95 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21.35 | |
| Amgen Inc. | 1 | $20.00 | |
| PFIZER INC. | 1 | $17.52 | |
| Lilly USA, LLC | 1 | $16.23 | |
| Dermavant Sciences, Inc. | 1 | $15.84 | |
| LEO Pharma Inc. | 1 | $14.78 | |
| Arcutis Biotherapeutics, Inc. | 1 | $14.49 | |
| Janssen Biotech, Inc. | 1 | $13.82 | |
| Verrica Pharmaceuticals Inc. | 1 | $13.51 | |
| Smith+Nephew, Inc. | 1 | $13.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
759
Patients
439
Total drug cost
$41,216
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 104 | 62 | $2,835 |
| Clobetasol Propionate | Generic | 102 | 53 | $8,944 |
| Triamcinolone Acetonide | Generic | 79 | 50 | $843 |
| Desonide | Generic | 71 | 58 | $6,169 |
| Metronidazole | Generic | 69 | 36 | $7,436 |
| Betamethasone Dipropionate | Generic | 54 | 29 | $2,968 |
| Fluocinonide | Generic | 52 | 37 | $3,406 |
| Doxycycline Hyclate | Generic | 51 | 17 | $1,867 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 44 | 24 | $2,193 |
| Ciclopirox | Generic | 33 | 26 | $1,452 |
Hospital affiliations
Frequently asked questions
What is Dr. Michelle Bussmann's medical specialty?
Dr. Michelle Bussmann practices Dermatology Physician in Edina, MN.
Where does Dr. Michelle Bussmann practice?
Dr. Michelle Bussmann practices at 3316 W 66Th St, Edina, MN 554352506. Office phone: 9529203808.
What is Dr. Michelle Bussmann's NPI?
Dr. Michelle Bussmann's National Provider Identifier (NPI) is 1811097579, issued by NPPES.
Does Dr. Michelle Bussmann accept Medicare assignment?
Yes. Dr. Michelle Bussmann accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michelle Bussmann commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.